VAPO-ISO Drug Patent Profile
✉ Email this page to a colleague
When do Vapo-iso patents expire, and when can generic versions of Vapo-iso launch?
Vapo-iso is a drug marketed by Fisons and is included in one NDA.
The generic ingredient in VAPO-ISO is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vapo-iso
A generic version of VAPO-ISO was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
Summary for VAPO-ISO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Patent Applications: | 963 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VAPO-ISO at DailyMed |
US Patents and Regulatory Information for VAPO-ISO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fisons | VAPO-ISO | isoproterenol hydrochloride | SOLUTION;INHALATION | 016813-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |